Large Cell Neuroendocrine Carcinoma
Also known as: Large-Cell Neuroendocrine Carcinoma / Large cell neuroendocrine carcinoma (morphologic abnormality)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB01234 | Dexamethasone | 1 / 2 | Terminated | 1 |
| DB13017 | Rovalpituzumab tesirine | 1 / 2 | Terminated | 1 |
| DB08875 | Cabozantinib | 2 | Recruiting | 1 |
| DB06186 | Ipilimumab | 2 | Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Recruiting | 1 |
| DB00853 | Temozolomide | 2 | Active Not Recruiting | 1 |